Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia

Russell A Miller; Yuji Shi; Wenyun Lu; David A Pirman; Aditi Jatkar; Matthew Blatnik; Hong Wu; César Cárdenas; Min Wan; J Kevin Foskett; Junyoung O Park; Yiyi Zhang; William L Holland; Joshua D Rabinowitz; Morris J Birnbaum

doi:10.1038/s41591-018-0047-1

Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia

Nat Med. 2018 Sep;24(9):1482. doi: 10.1038/s41591-018-0047-1.

Authors

Russell A Miller^{1

2}, Yuji Shi³, Wenyun Lu⁴, David A Pirman⁵, Aditi Jatkar³, Matthew Blatnik⁵, Hong Wu⁵, César Cárdenas^{6

7

8

9}, Min Wan³, J Kevin Foskett^{10

11}, Junyoung O Park^{4

12}, Yiyi Zhang¹³, William L Holland¹³, Joshua D Rabinowitz⁴, Morris J Birnbaum^{14

15

16}

Affiliations

¹ Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. russell.miller@pfizer.com.
² Pfizer Internal Medicine Research Units, Cambridge, Massachusetts, USA. russell.miller@pfizer.com.
³ Pfizer Internal Medicine Research Units, Cambridge, Massachusetts, USA.
⁴ Chemistry and Integrative Genomics, Princeton University, Princeton, New Jersey, USA.
⁵ Pfizer Worldwide Research and Development, Groton, Connecticut, USA.
⁶ Anatomy and Developmental Biology Program, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.
⁷ Geroscience Center for Brain Health and Metabolism, Santiago, Chile.
⁸ Buck Institute for Research on Aging, Novato, California, USA.
⁹ Department of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, California, USA.
¹⁰ Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹¹ Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹² Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.
¹³ Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
¹⁴ Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. morris.birnbaum@pfizer.com.
¹⁵ Pfizer Internal Medicine Research Units, Cambridge, Massachusetts, USA. morris.birnbaum@pfizer.com.
¹⁶ Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. morris.birnbaum@pfizer.com.

PMID: 29895835
DOI: 10.1038/s41591-018-0047-1

Abstract

In the version of this article initially published, the "[13C2]α-ketoglutarate" label on Fig. 1g is incorrect. It should be "[13C5]α-ketoglutarate". Additionally, in Fig. 3b, the "AAV-GFP" group is missing a notation for significance, and in Fig. 3c, the "AAV-GLS2-sh" group is missing a notation for significance. There should be a double asterisk notating significance in both panels. Finally, in the Fig. 4g legend, "[13C6]UDP-glucose" should be "[13C3]UDP-glucose", and in the Fig. 4h legend, "[13C6]hexose" should be "[13C3]hexose". The errors have been corrected in the HTML and PDF versions of this article.

Publication types

Published Erratum